Drugs / Eplernone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04078425 | Mar 2020 → Mar 2022 | heart failure | Assiut University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eplernone | “traditional anti-failure treatment in addition to aldosterone antagonist (Eplernone) with follow up echocardiography and aldosterone level before and after” NCT04078425 ↗ |
| Action | Inhibit | “There is evidence that aldosterone antagonists can oppose the effect of aldosterone in promoting cardiac fibrosis.” NCT04078425 ↗ |